bgb-11417,zanubrutinib
beigene
['lymsm', 'bgb-11417', 'zanubrutinib', 'cll', 'leusm']
bgb-11417 alone or in combination with zanubrutinib shows early efficacy in cll/sll #ash22 #leusm #lymsm 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.